NSE BSE
sms pharmaceuticals ltd. stock

SMS PHARMACEUTICALS LTD. Share Price

- - (%)
- NSE: SMSPHARMA

SMS PHARMACEUTICALS LTD. Share Price Update

As of the latest trading session, SMS PHARMACEUTICALS LTD. share price is currently at 240.41, which is down by -5.91 from its previous closing. Today, the stock has fluctuated between 239.12 and 246.62. Over the past year, SMS PHARMACEUTICALS LTD. has achieved a return of 141.49 %. In the last month alone, the return has been 18.07 %. Read More...

SMS PHARMACEUTICALS LTD. Performance

Day Range

Low239.12 High246.62
240.41

52 Week Range

Low 100.80 High 263.73
240.41

SMS PHARMACEUTICALS LTD. Share Price

14329

532815

SMSPHARMA

img img img img
No Data Available

Open Price

246.32

Prev. Close

246.32

Volume (Shares)

134693.00

Total traded value

323.81

Upper Circuit

295.58

Lower Circuit

197.05

Note: The current prices & values are delayed, Login to your account for live updates.

SMS PHARMACEUTICALS LTD. Fundamentals


(Standalone)

Market Cap (Cr) 2035.12
PE Ratio (TTM) 42.08
Book Value / Share 67.39
Beta 0.69
ROE 0.83%
EPS (TTM) 5.84
Dividend Yield 0.00%
Net Profit Qtr (Cr) 15.92

SMS PHARMACEUTICALS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 245.80
Operating Expense 225.84
Net Profit 15.92
Net Profit Margin (%) 6.47
Earnings Per Share (EPS) 1.88
EBITDA 35.14
Effective Tax Rate (%) 26.33
Particulars DEC 2023 (Values in Cr)
Revenue 161.48
Operating Expense 146.56
Net Profit 12.17
Net Profit Margin (%) 7.53
Earnings Per Share (EPS) 1.44
EBITDA 30.36
Effective Tax Rate (%) 25.83
Particulars SEP 2023 (Values in Cr)
Revenue 166.64
Operating Expense 152.29
Net Profit 12.05
Net Profit Margin (%) 7.23
Earnings Per Share (EPS) 1.42
EBITDA 28.63
Effective Tax Rate (%) 20.51
Particulars JUN 2023 (Values in Cr)
Revenue 135.34
Operating Expense 122.69
Net Profit 9.28
Net Profit Margin (%) 6.85
Earnings Per Share (EPS) 1.10
EBITDA 27.17
Effective Tax Rate (%) 29.40
Particulars MAR 2023 (Values in Cr)
Revenue 149.43
Operating Expense 140.04
Net Profit 8.07
Net Profit Margin (%) 5.40
Earnings Per Share (EPS) 0.95
EBITDA 24.50
Effective Tax Rate (%) 24.15
Particulars MAR 2024 (Values in Cr)
Revenue 709.26
Operating Expense 647.39
Net Profit 49.42
Net Profit Margin (%) 6.96
Earnings Per Share (EPS) 5.84
EBITDA 121.30
Effective Tax Rate (%) 25.49
Particulars MAR 2023 (Values in Cr)
Revenue 522.05
Operating Expense 521.41
Net Profit 4.08
Net Profit Margin (%) 0.78
Earnings Per Share (EPS) 0.48
EBITDA 59.59
Effective Tax Rate (%) 26.48
Particulars MAR 2022 (Values in Cr)
Revenue 519.87
Operating Expense 456.42
Net Profit 68.04
Net Profit Margin (%) 13.08
Earnings Per Share (EPS) 8.04
EBITDA 119.68
Effective Tax Rate (%) 0.90
Particulars MAR 2021 (Values in Cr)
Revenue 563.18
Operating Expense 475.51
Net Profit 60.96
Net Profit Margin (%) 10.82
Earnings Per Share (EPS) 7.20
EBITDA 124.56
Effective Tax Rate (%) 33.09
Particulars MAR 2020 (Values in Cr)
Revenue 411.95
Operating Expense 366.29
Net Profit 32.69
Net Profit Margin (%) 7.93
Earnings Per Share (EPS) 3.86
EBITDA 85.03
Effective Tax Rate (%) 35.59
Particulars MAR 2023 (Values in Cr)
Book Value / Share 54.40
ROE % 0.83
ROCE % 3.77
Total Debt to Total Equity 0.56
EBITDA Margin 10.72
Particulars MAR 2022 (Values in Cr)
Book Value / Share 55.56
ROE % 15.41
ROCE % 12.50
Total Debt to Total Equity 0.59
EBITDA Margin 21.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 48.50
ROE % 16.07
ROCE % 17.43
Total Debt to Total Equity 0.54
EBITDA Margin 20.37
Particulars MAR 2020 (Values in Cr)
Book Value / Share 41.14
ROE % 9.76
ROCE % 12.95
Total Debt to Total Equity 0.45
EBITDA Margin 18.78
Particulars MAR 2019 (Values in Cr)
Book Value / Share 38.03
ROE % 13.67
ROCE % 16.50
Total Debt to Total Equity 0.48
EBITDA Margin 18.29
Particulars MAR 2023 (Values in Cr)
Book Value / Share 58.49
ROE % 0.83
ROCE % 3.65
Total Debt to Total Equity 0.52
EBITDA Margin 10.76
Particulars MAR 2022 (Values in Cr)
Book Value / Share 58.33
ROE % 14.76
ROCE % 12.17
Total Debt to Total Equity 0.56
EBITDA Margin 21.60
Particulars MAR 2021 (Values in Cr)
Book Value / Share 50.59
ROE % 15.32
ROCE % 16.90
Total Debt to Total Equity 0.52
EBITDA Margin 20.37
Particulars MAR 2020 (Values in Cr)
Book Value / Share 43.40
ROE % 9.24
ROCE % 12.47
Total Debt to Total Equity 0.43
EBITDA Margin 18.78
Particulars MAR 2019 (Values in Cr)
Book Value / Share 40.16
ROE % 12.93
ROCE % 15.89
Total Debt to Total Equity 0.45
EBITDA Margin 18.29
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 7.46
Total Assets 879.61
Total Liabilities 879.61
Total Equity 460.52
Share Outstanding 84652030
Price to Book Ratio 0.99
Return on Assets (%) -0.80
Return on Capital (%) -0.99
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 46.66
Total Assets 859.50
Total Liabilities 859.50
Total Equity 470.28
Share Outstanding 84652030
Price to Book Ratio 1.61
Return on Assets (%) 7.23
Return on Capital (%) 8.52
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 40.50
Total Assets 812.21
Total Liabilities 812.21
Total Equity 410.52
Share Outstanding 84652030
Price to Book Ratio 2.46
Return on Assets (%) 7.69
Return on Capital (%) 9.46
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 9.65
Total Assets 607.91
Total Liabilities 607.91
Total Equity 348.23
Share Outstanding 84652030
Price to Book Ratio 0.61
Return on Assets (%) 5.19
Return on Capital (%) 6.61
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 14.87
Total Assets 558.81
Total Liabilities 558.81
Total Equity 321.91
Share Outstanding 84652030
Price to Book Ratio 1.55
Return on Assets (%) 7.16
Return on Capital (%) 8.8
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 7.46
Total Assets 914.18
Total Liabilities 914.18
Total Equity 495.09
Share Outstanding 84652030
Price to Book Ratio 0.99
Return on Assets (%) 0.44
Return on Capital (%) 0.55
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 46.66
Total Assets 882.97
Total Liabilities 882.97
Total Equity 493.76
Share Outstanding 84652030
Price to Book Ratio 1.61
Return on Assets (%) 7.70
Return on Capital (%) 9.02
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 40.50
Total Assets 829.90
Total Liabilities 829.90
Total Equity 428.22
Share Outstanding 84652030
Price to Book Ratio 2.46
Return on Assets (%) 7.34
Return on Capital (%) 8.98
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 9.65
Total Assets 627.10
Total Liabilities 627.10
Total Equity 367.42
Share Outstanding 84652030
Price to Book Ratio 0.61
Return on Assets (%) 5.21
Return on Capital (%) 6.58
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 14.87
Total Assets 576.82
Total Liabilities 576.82
Total Equity 339.92
Share Outstanding 84652030
Price to Book Ratio 1.55
Return on Assets (%) 7.18
Return on Capital (%) 8.77
Particulars MAR 2023 (Values in Cr)
Net Income 5.34
Cash from Operations 27.05
Cash from Investing -29.68
Cash from Financing -31.96
Net change in Cash -39.20
Free Cash Flow 56.97
Particulars MAR 2022 (Values in Cr)
Net Income 68.49
Cash from Operations 59.98
Cash from Investing -27.15
Cash from Financing -11.74
Net change in Cash 6.15
Free Cash Flow 87.22
Particulars MAR 2021 (Values in Cr)
Net Income 91.11
Cash from Operations 106.49
Cash from Investing -151.59
Cash from Financing 92.01
Net change in Cash 30.87
Free Cash Flow 258.24
Particulars MAR 2020 (Values in Cr)
Net Income 50.75
Cash from Operations 51.81
Cash from Investing -42.56
Cash from Financing -2.40
Net change in Cash -5.25
Free Cash Flow 94.54
Particulars MAR 2019 (Values in Cr)
Net Income 62.35
Cash from Operations 63.13
Cash from Investing -34.67
Cash from Financing -12.91
Net change in Cash 2.16
Free Cash Flow 97.97
Particulars MAR 2023 (Values in Cr)
Net Income 5.54
Cash from Operations 27.05
Cash from Investing -29.68
Cash from Financing -31.96
Net change in Cash -39.20
Free Cash Flow 56.97
Particulars MAR 2022 (Values in Cr)
Net Income 68.65
Cash from Operations 59.98
Cash from Investing -27.15
Cash from Financing -11.74
Net change in Cash 6.15
Free Cash Flow 87.22
Particulars MAR 2021 (Values in Cr)
Net Income 91.11
Cash from Operations 106.49
Cash from Investing -151.59
Cash from Financing 92.01
Net change in Cash 30.87
Free Cash Flow 258.24
Particulars MAR 2020 (Values in Cr)
Net Income 50.75
Cash from Operations 51.81
Cash from Investing -42.56
Cash from Financing -2.40
Net change in Cash -5.25
Free Cash Flow 94.54
Particulars MAR 2019 (Values in Cr)
Net Income 62.35
Cash from Operations 63.13
Cash from Investing -34.67
Cash from Financing -12.91
Net change in Cash 2.16
Free Cash Flow 97.97
Company Name Price P/E P/B Market Cap 52 Week Low/High
SMS PHARMACEUTICALS LTD. 245.75 41.72 3.87 2080.32 100.72 / 265.00
BLISS GVS PHARMA LTD 114.00 12.46 1.23 1194.01 77.65 / 148.95
CIPLA LTD 1511.35 28.66 4.56 122044.23 1020.00 / 1581.70
FERMENTA BIOTECH LIMITED 213.15 0.00 2.16 627.32 136.60 / 219.05
GLAXOSMITHKLINE PHARMA LT 2611.55 67.38 24.88 44241.23 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
SMS PHARMACEUTICALS LTD. 245.75 42.08 3.64 2080.32 100.72 / 265.00
AMRUTAJAN HEALTH LTD 742.65 47.73 7.44 2147.05 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6566.50 109.81 23.05 16416.25 3715.05 / 7550.00
BLISS GVS PHARMA LTD 114.00 15.68 1.20 1194.01 77.65 / 148.95
ABBOTT INDIA LIMITED 28602.85 50.60 16.43 60781.06 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 247.50
  • 26 Days 235.00
  • 10 Days 247.80
  • 50 Days 223.80
  • 12 Days 244.90
  • 100 Days 205.70
  • 20 Days 239.60
  • 200 Days 130.40
248.11
PIVOT
First Resistance 251.21
Second Resistance 256.11
Third Resistance 259.21
First Support 243.21
Second Support 240.11
Third Support 235.21
RSI 62.96
MACD 9.92
Commodity Channel Index (CCI) 49.97
ADX 50.82
Williams % R -38.59

Over 1 Month

down

18.07

Over 3 Months

down

17.80

Over 6 Months

down

94.10

Over 1 Year

down

141.49

Over 3 Years

down

10.58

Over 5 Years

down

38.98

SMS PHARMACEUTICALS LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

SMS PHARMACEUTICALS LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
33.02
Promoter Holdings
64.67
FII
0.17
DII
2.13
Promoter Shares(Pledge Percentage)
19.4
Name Category Shares Shares%
Ramesh Babu Potluri Shareholding of Promoter and Promoter Group 1.565306E7 18.49
Hima Bindu Potluri Shareholding of Promoter and Promoter Group 1.500884E7 17.73
Vamsi Krishna Potluri Shareholding of Promoter and Promoter Group 1.332837E7 15.74
Potluri Infra Projects Llp Shareholding of Promoter and Promoter Group 7346420.0 8.68
Trilok Potluri Shareholding of Promoter and Promoter Group 2188000.0 2.58
Quant Mutual Fund - Quant Healthcare Fund Public Shareholding 1803886.0 2.13
Venkata Subbaraju Penmatsa . Public Shareholding 1799900.0 2.13
Venkata Praveen Talluri Public Shareholding 1320170.0 1.56
Sudeepthi Gopineedi Public Shareholding 1320170.0 1.56
Potluri Laboratories Private Limited Shareholding of Promoter and Promoter Group 1120320.0 1.32
Vivek Mundra Public Shareholding 1043628.0 1.23
Aniruddh Mundra Public Shareholding 960000.0 1.13
Tvt Infracon Llp Shareholding of Promoter and Promoter Group 100000.0 0.12

SMS PHARMACEUTICALS LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-22 0.3 Final 2023-09-22 Equity shares 2022-09-22 0.3 Final 2022-09-23 Equity shares 2021-09-22 0.3 Final 2021-09-24 Equity shares 2020-03-26 0.25 Interim 2020-03-28 Equity shares 2019-09-19 0.25 Final 2019-09-23 Equity shares 2018-09-11 0.25 Final 2018-09-13 Equity shares 2017-09-20 0.2 Final 2017-09-22 Equity shares 2016-09-22 0.2 Final 2016-09-24 Equity shares 2015-09-22 2.0 Final 2015-09-24 Equity shares 2014-09-23 2.0 Final 2014-09-25 Equity shares 2013-09-23 2.0 Final 2013-09-25 Equity shares 2011-09-22 1.5 Final 2011-09-24 Equity shares 2010-09-23 1.0 Final 2010-09-25 Equity shares 2009-09-23 2.0 Final 2009-09-25 Equity shares 2008-12-23 2.0 Final 2008-12-26 Equity shares 2007-09-21 2.0 Final 2007-09-25 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2015-12-17 10.0 1.0 2015-12-18

Learn More About Stocks

About SMS PHARMACEUTICALS LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by SMS PHARMACEUTICALS LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of SMS Pharmaceuticals Ltd?

Answer Field

The share price of SMS Pharmaceuticals Ltd for NSE is ₹ 240.41 and for BSE is ₹ 239.85.

What is the Market Cap of SMS Pharmaceuticals Ltd?

Answer Field

The market cap of SMS Pharmaceuticals Ltd for NSE is ₹ 2,035.12 Cr. and for BSE is ₹ 2,030.37 Cr. as of now.

What is the 52 Week High and Low of SMS Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of SMS Pharmaceuticals Ltd for NSE is ₹ 263.73 and ₹ 100.80 and for BSE is ₹ 265.00 and ₹ 100.72.

How to Buy SMS Pharmaceuticals Ltd share?

Answer Field

You can trade in SMS Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for SMS Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 141.49%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader